Indomethacin, a nonsteroidal anti-inflammatory agent, is a potent inhibitor
of ovulation in vertebrates. The presumptive ob ligate anovulatory mode of
indomethacin action is via suppression of ovarian prostaglandin production
. We report that a very high systemic dose of indomethacin (800 mg i.m.) is
required to block ovulation in gonadotropin-treated anestrous ewes, A lowe
r dose of indomethacin (200 mg), which negated the preovulatory rise in fol
licular prostaglandin (PGF(2 alpha)) biosynthesis, did not prevent ovulatio
n, Endothelial secretion of tumor necrosis factor (TNF)-alpha within the ap
ical follicular wall (prospective site of rupture) was not altered by indom
ethacin; notwithstanding, the apoptosis (DNA-fragmentation)-inducing effect
of TNF-alpha (a determinant of ovulatory stigma formation) was attenuated
by 800 (but not 200) mg indomethacin, A suprapharmacological concentration
of indomethacin also was necessary to protect ovarian surface epithelial ce
lls from a (prostaglandin-independent) cytotoxic effect of TNF-alpha in vit
ro. It is concluded that indomethacin inhibits ovulation by anti-apoptotic
mechanisms that can be dissociated from the paradigm of prostanoid down-reg
ulation.